New Pfizer COVID-19 pill cut hospital, death risk by 90%: study

Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90 per cent as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

from Google Alert - Business https://ift.tt/31xxcZ7
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90 per cent as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize